Cargando…

Application of Metabolomics in Drug Resistant Breast Cancer Research

The metabolic profiles of breast cancer cells are different from normal mammary epithelial cells. Breast cancer cells that gain resistance to therapeutic interventions can reprogram their endogenous metabolism in order to adapt and proliferate despite high oxidative stress and hypoxic conditions. Dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shajahan-Haq, Ayesha N., Cheema, Mehar S., Clarke, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381292/ https://www.ncbi.nlm.nih.gov/pubmed/25693144 http://dx.doi.org/10.3390/metabo5010100

Ejemplares similares

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
por: Scheidemann, Erin R., et al.
Publicado: (2021)

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2017)

MYC-Driven Pathways in Breast Cancer Subtypes
por: Fallah, Yassi, et al.
Publicado: (2017)

Modeling breast cancer proliferation, drug synergies, and alternating therapies
por: He, Wei, et al.
Publicado: (2023)

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N, et al.
Publicado: (2014)

The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer
por: Schwartz, J. L., et al.
Publicado: (2011)

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
por: Demas, Diane M., et al.
Publicado: (2019)

Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
por: He, Wei, et al.
Publicado: (2020)

Applications of metabolomics in cancer research
por: Vermeersch, Kathleen A., et al.
Publicado: (2013)

Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer
por: Bakewell, Suzanne, et al.
Publicado: (2020)

Metabolomics in drug research and development: The recent advances in technologies and applications
por: Pang, Huanhuan, et al.
Publicado: (2023)

Application of Metabolomics in Thyroid Cancer Research
por: Wojakowska, Anna, et al.
Publicado: (2015)

Application of Metabolomics in Fungal Research
por: Li, Guangyao, et al.
Publicado: (2022)

Application of metabolomics in the diagnosis of breast cancer: a systematic review
por: Yang, Liqing, et al.
Publicado: (2020)

Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis
por: Sverdlov, Maria, et al.
Publicado: (2007)

Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016)

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
por: Chen, Yinnan, et al.
Publicado: (2018)

NMR-Based Metabolomics in Metal-Based Drug Research
por: De Castro, Federica, et al.
Publicado: (2019)

Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
por: Ahmed, Munazza, et al.
Publicado: (2022)

BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency
por: Shi, Xu, et al.
Publicado: (2015)

Co-Inhibition of BCL-W and BCL2 Restores Antiestrogen Sensitivity through BECN1 and Promotes an Autophagy-Associated Necrosis
por: Crawford, Anatasha C., et al.
Publicado: (2010)

ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles
por: Chen, Xi, et al.
Publicado: (2016)

MRS-based Metabolomics in Cancer Research
por: Bezabeh, Tedros, et al.
Publicado: (2014)

Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research
por: Lv, Huanhuan, et al.
Publicado: (2016)

Serum metabolomics of treatment response in myasthenia gravis
por: Sikorski, Patricia, et al.
Publicado: (2023)

Application of metabolomics in osteoporosis research
por: Zhao, Zhenyu, et al.
Publicado: (2022)

From Metabolite to Metabolome: Metabolomics Applications in Plasmodium Research
por: Yu, Xinyu, et al.
Publicado: (2021)

Metabolomics of Breast Cancer: A Review
por: Subramani, Ramadevi, et al.
Publicado: (2022)

Applications of microarray technology in breast cancer research
por: Cooper, Colin S
Publicado: (2001)

Progress in the application of organoids to breast cancer research
por: Yang, Liping, et al.
Publicado: (2020)

Application of Microfluidic Systems for Breast Cancer Research
por: Frankman, Zachary D., et al.
Publicado: (2022)

mAPC-GibbsOS: an integrated approach for robust identification of gene regulatory networks
por: Shi, Xu, et al.
Publicado: (2013)

A Review of Applications of Metabolomics in Cancer
por: Beger, Richard D.
Publicado: (2013)

The ABRF Metabolomics Research Group 2016 Exploratory Study: Investigation of Data Analysis Methods for Untargeted Metabolomics
por: Turck, Christoph W., et al.
Publicado: (2020)

Metabolomics in Alcohol Research and Drug Development
por: Harrigan, George G., et al.
Publicado: (2008)

Metabolomics in Bone Research
por: Fan, Jingzhi, et al.
Publicado: (2021)

Exosomes and breast cancer drug resistance
por: Dong, Xingli, et al.
Publicado: (2020)

Genetic Influences in Breast Cancer Drug Resistance
por: Daniyal, Adhitiya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5meminr66un0kda30jhn4csj3